Jean-Bosco Ouédraogo

Jean-Bosco Ouédraogo

Auto-generated profile, based on publicly available information

Jean-Bosco Ouédraogo

Institute of Health Science Research, Bobo-Dioulasso, Burkina Faso

Research Focus & Metrics

Academic Career Length

40Years (1987-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 June 2012 in Nature
Verified
Journal Article
Open access
PDF file
MMMagnus Manske
Magnus Manske
OMOlivo Miotto
Olivo Miotto
SCSusana Campino
Susana Campino
SASarah Auburn
Sarah Auburn
JAJacob Almagro-Garcia
Jacob Almagro-Garcia
DKDominic P. Kwiatkowski
Dominic P. Kwiatkowski
Next-generation sequencing is used here to analyse Plasmodium falciparum genome variation directly from clinical blood samples, as well as cultured isolates, from Africa, Asia and Oceania. Resistance to the major antimalarial drug artemisinin is emerging in the Plasmodium falciparum parasite across Southeast Asia, and there is concern that the increased deployment of antimalarials in pursuit of disease eradication might simply lead to increased drug resistance. To monitor these risks it is important to survey the parasite population for genetic changes. Next-generation sequencing is used here to analyse P. falciparum genome variation directly from nearly 300 clinical blood samples, and from cultured isolates from Africa, Asia and Oceania. The authors use these data to analyse the diversity of the parasite population across different geographical locations, as well as within-host diversity at the level of the whole genome, and they show how this may be used to estimate inbreeding rates, which are important for the evolution of drug resistance. Malaria elimination strategies require surveillance of the parasite population for genetic changes that demand a public health response, such as new forms of drug resistance1,2. Here we describe methods for the large-scale analysis of genetic variation in Plasmodium falciparum by deep sequencing of parasite DNA obtained from the blood of patients with malaria, either directly or after short-term culture. Analysis of 86,158 exonic single nucleotide polymorphisms that passed genotyping quality control in 227 samples from Africa, Asia and Oceania provides genome-wide estimates of allele frequency distribution, population structure and linkage disequilibrium. By comparing the genetic diversity of individual infections with that of the local parasite population, we derive a metric of within-host diversity that is related to the level of inbreeding in the population. An open-access web application has been established for the exploration of regional differences in allele frequency and of highly differentiated loci in the P. falciparum genome.

23 June 2016 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
Didier MenardDidier Menard
Didier Menard
NKNimol Khim
Nimol Khim
JBJohann Beghain
Johann Beghain
AAAyola A. Adegnika
Ayola A. Adegnika
SAShafiul Alam
Shafiul Alam
OMOdile Mercereau-Puijalon
Odile Mercereau-Puijalon
Recent gains in reducing the global burden of malaria are threatened by the emergence of Plasmodium falciparum resistance to artemisinins. The discovery that mutations in portions of a P. falciparum gene encoding kelch (K13)–propeller domains are the major determinant of resistance has provided opportunities for monitoring such resistance on a global scale. We analyzed the K13-propeller sequence polymorphism in 14,037 samples collected in 59 countries in which malaria is endemic. Most of the samples (84.5%) were obtained from patients who were treated at sentinel sites used for nationwide surveillance of antimalarial resistance. We evaluated the emergence and dissemination of mutations by haplotyping neighboring loci. We identified 108 nonsynonymous K13 mutations, which showed marked geographic disparity in their frequency and distribution. In Asia, 36.5% of the K13 mutations were distributed within two areas — one in Cambodia, Vietnam, and Laos and the other in western Thailand, Myanmar, and China — with no overlap. In Africa, we observed a broad array of rare nonsynonymous mutations that were not associated with delayed parasite clearance. The gene-edited Dd2 transgenic line with the A578S mutation, which expresses the most frequently observed African allele, was found to be susceptible to artemisinin in vitro on a ring-stage survival assay. No evidence of artemisinin resistance was found outside Southeast Asia and China, where resistance-associated K13 mutations were confined. The common African A578S allele was not associated with clinical or in vitro resistance to artemisinin, and many African mutations appear to be neutral. (Funded by Institut Pasteur Paris and others.)

28 April 2013 in Nature Genetics
Verified
Journal Article
Open access
PDF file
OMOlivo Miotto
Olivo Miotto
JAJacob Almagro-Garcia
Jacob Almagro-Garcia
MMMagnus Manske
Magnus Manske
BMBronwyn MacInnis
Bronwyn MacInnis
SCSusana Campino
Susana Campino
DKDominic P Kwiatkowski
Dominic P Kwiatkowski
Dominic Kwiatkowski and colleagues report analysis of genetic variation in 826 Plasmodium falciparum samples collected from 10 locations in West Africa and southeast Asia. They characterize the population structure of this parasite in Cambodia and find evidence for multiple distinct subpopulations showing high levels of genetic differentiation and artemisinin resistance. We describe an analysis of genome variation in 825 P. falciparum samples from Asia and Africa that identifies an unusual pattern of parasite population structure at the epicenter of artemisinin resistance in western Cambodia. Within this relatively small geographic area, we have discovered several distinct but apparently sympatric parasite subpopulations with extremely high levels of genetic differentiation. Of particular interest are three subpopulations, all associated with clinical resistance to artemisinin, which have skewed allele frequency spectra and high levels of haplotype homozygosity, indicative of founder effects and recent population expansion. We provide a catalog of SNPs that show high levels of differentiation in the artemisinin-resistant subpopulations, including codon variants in transporter proteins and DNA mismatch repair proteins. These data provide a population-level genetic framework for investigating the biological origins of artemisinin resistance and for defining molecular markers to assist in its elimination.

1 October 2014 in The American Journal of Tropical Medicine and Hygiene
Verified
Journal Article
Open access
MVMeera Venkatesan
Meera Venkatesan
NGNahla B. Gadalla
Nahla B. Gadalla
KSKasia Stepniewska
Kasia Stepniewska
PDPrabin Dahal
Prabin Dahal
CNChristian Nsanzabana
Christian Nsanzabana
AGASAQ Molecular Marker Study Group
ASAQ Molecular Marker Study Group
Adequate clinical and parasitologic cure by artemisinin combination therapies relies on the artemisinin component and the partner drug. Polymorphisms in the Plasmodium falciparum chloroquine resistance transporter (pfcrt) and P. falciparum multidrug resistance 1 (pfmdr1) genes are associated with decreased sensitivity to amodiaquine and lumefantrine, but effects of these polymorphisms on therapeutic responses to artesunate-amodiaquine (ASAQ) and artemether-lumefantrine (AL) have not been clearly defined. Individual patient data from 31 clinical trials were harmonized and pooled by using standardized methods from the WorldWide Antimalarial Resistance Network. Data for more than 7,000 patients were analyzed to assess relationships between parasite polymorphisms in pfcrt and pfmdr1 and clinically relevant outcomes after treatment with AL or ASAQ. Presence of the pfmdr1 gene N86 (adjusted hazards ratio = 4.74, 95% confidence interval = 2.29 – 9.78, P < 0.001) and increased pfmdr1 copy number (adjusted hazards ratio = 6.52, 95% confidence interval = 2.36–17.97, P < 0.001) were significant independent risk factors for recrudescence in patients treated with AL. AL and ASAQ exerted opposing selective effects on single-nucleotide polymorphisms in pfcrt and pfmdr1. Monitoring selection and responding to emerging signs of drug resistance are critical tools for preserving efficacy of artemisinin combination therapies; determination of the prevalence of at least pfcrt K76T and pfmdr1 N86Y should now be routine.

6 January 2015 in Nature Communications
Verified
Journal Article
Open access
PDF file
MGMathilde Gendrin
Mathilde Gendrin
FRFaye H. Rodgers
Faye H. Rodgers
RYRakiswendé S. Yerbanga
Rakiswendé S. Yerbanga
JOJean Bosco Ouédraogo
Jean Bosco Ouédraogo
MBMaría-Gloria Basáñez
María-Gloria Basáñez
GCGeorge K. Christophides
George K. Christophides
Malaria reduction is most efficiently achieved by vector control whereby human populations at high risk of contracting and transmitting the disease are protected from mosquito bites. Here, we identify the presence of antibiotics in the blood of malaria-infected people as a new risk of increasing disease transmission. We show that antibiotics in ingested blood enhance the susceptibility of Anopheles gambiae mosquitoes to malaria infection by disturbing their gut microbiota. This effect is confirmed in a semi-natural setting by feeding mosquitoes with blood of children naturally infected with Plasmodium falciparum. Antibiotic exposure additionally increases mosquito survival and fecundity, which are known to augment vectorial capacity. These findings suggest that malaria transmission may be exacerbated in areas of high antibiotic usage, and that regions targeted by mass drug administration programs against communicable diseases may necessitate increased vector control.

13 June 2014 in Nature Communications
Verified
Journal Article
Open access
PDF file
MPMark D. Preston
Mark D. Preston
SCSusana Campino
Susana Campino
SASamuel A. Assefa
Samuel A. Assefa
DEDiego F. Echeverry
Diego F. Echeverry
HOHarold Ocholla
Harold Ocholla
Taane ClarkTaane Clark
Taane Clark
Malaria is a major public health problem that is actively being addressed in a global eradication campaign. Increased population mobility through international air travel has elevated the risk of re-introducing parasites to elimination areas and dispersing drug-resistant parasites to new regions. A simple genetic marker that quickly and accurately identifies the geographic origin of infections would be a valuable public health tool for locating the source of imported outbreaks. Here we analyse the mitochondrion and apicoplast genomes of 711 Plasmodium falciparum isolates from 14 countries, and find evidence that they are non-recombining and co-inherited. The high degree of linkage produces a panel of relatively few single-nucleotide polymorphisms (SNPs) that is geographically informative. We design a 23-SNP barcode that is highly predictive (~92%) and easily adapted to aid case management in the field and survey parasite migration worldwide.